TYRA CIK: 1863127

Tyra Biosciences, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
millions USD
FY21:
−23.7
FY22:
−50.3
FY23:
−50.1
FY24:
−69.8
FY25:
−95.1
Change from FY21 to FY25
millions USD
FY21:
−0.65
FY22:
−0.56
FY23:
−145
FY24:
−98.4
FY25:
72.5
Change from FY21 to FY25
millions USD
FY21:
311
FY22:
0.63
FY23:
1.54
FY24:
202
FY25:
8.10
millions USD
FY21:
287
FY22:
−50.2
FY23:
−193
FY24:
34.0
FY25:
−14.6
(positive)
Change from FY21 to FY25
millions USD
FY21:
−24.4
FY22:
−50.8
FY23:
−50.9
FY24:
−70.4
FY25:
−95.3

All amounts in millions USD Data source:SEC EDGAR